IRAK4 and Splenomegaly: In contrast, the pMo in the blood of control ABIN1[D485N] mice not given the IRAK4 inhibitor continued to increase, and these mice developed splenomegaly, auto-antibodies, glomerulonephritis, liver pathology, and lung inflammation (Figs 8A–G).